AKTS

Aktis Oncology Inc. Common stock (AKTS)

Stock · NASDAQ · Health Care

$25.78as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$18.96
Industry
Biotechnology: Pharmaceutical Preparations

Aktis Oncology Inc. Common stock Competitors

Chosen by industry and closest market cap.

  • AKTS
    Aktis Oncology Inc. Common stock
    $25.78
    ▼ 1.53%
    Market cap $1.23BP/E
  • LBRX
    LB Pharmaceuticals Inc Common Stock
    $47.8
    ▼ 0.20%
    Market cap $1.23BP/E
    $13.36$50.16
  • ARDX
    Ardelyx Inc. Common Stock
    $3.81
    ▼ 0.26%
    Market cap $1.23BP/E
    $3.73$8.4
  • ETON
    Eton Pharmaceuticals Inc. Common Stock
    $59.79
    ▼ 4.60%
    Market cap $1.24BP/E 150.92
    $14.27$66.37
  • MNKD
    MannKind Corporation Common Stock
    $3.96
    ▼ 2.59%
    Market cap $1.21BP/E
    $2.23$6.51
  • SDGR
    Schrodinger Inc. Common Stock
    $19.7
    ▼ 3.48%
    Market cap $1.14BP/E
    $10.95$23.02
  • CRVS
    Corvus Pharmaceuticals Inc. Common Stock
    $14.15
    ▼ 3.87%
    Market cap $1.12BP/E
    $5.28$26.95

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
34.45M
Total value held
$550.33M
Institutional holders
65
Top holders this quarter
  • Unknown4.84M
  • Unknown4.82M
  • Unknown3.16M
  • Unknown2.32M
  • Unknown2.12M
  • Unknown2.11M
  • Unknown1.59M
  • Unknown1.56M
  • Unknown1.50M
  • Unknown1.45M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.